[DUHRING-BROCQ DISEASE IN CHILDREN. APROPOS OF 9 CASES].
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D002648:Child; D003874:Dermatitis Herpetiformis; D004358:Drug Therapy; D006801:Humans; D006967:Hypersensitivity; D007239:Infections; D008293:Malates; D010336:Pathology; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013432:Sulfathiazoles; D013449:Sulfonamides; D014221:Triamcinolone
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D008293:Malates; D013424:Sulfanilamides; D013432:Sulfathiazoles; D013449:Sulfonamides; D014221:Triamcinolone; D000077145:Sulfanilamide
ANTIBIOTICS; CHILD; DERMATITIS HERPETIFORMIS; DRUG THERAPY; HYPERSENSITIVITY; INFECTION; MALATES; PATHOLOGY; SULFATHIAZOLES; SULFONAMIDES; TRIAMCINOLONE
LA MALADIE DE DUHRING-BROCQ DE L'ENFANT. A PROPOS DE 9 OBSERVATIONS.